Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

CHEB

From Wikipedia, the free encyclopedia
Convulsant barbiturate
CHEB[1]
Names
IUPAC name
5-(2-Cyclohexylideneethyl)-5-ethyl-1,3-diazinane-2,4,6-trione
Other names
  • CHEB
  • 5-(2-cyclohexylidene-ethyl)-5-ethyl barbituric acid
  • 5-(2-cyclohexylidene-ethyl)-5-ethyl barbiturate
  • BRN 0250312
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • Key: AVSLJNHOEKBNAF-UHFFFAOYSA-N
  • InChI=1S/C14H20N2O3/c1-2-14(9-8-10-6-4-3-5-7-10)11(17)15-13(19)16-12(14)18/h8H,2-7,9H2,1H3,(H2,15,16,17,18,19)
  • CCC1(C(=O)NC(=O)NC1=O)CC=C2CCCCC2
Properties
C14H20N2O3
Molar mass264.325 g·mol−1
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

CHEB, also known asBRN 0250312 is aconvulsantbarbiturate. Its mechanism of action is not fully understood.

Pharmacodynamics

[edit]

CHEB has uncommon action compared to otherbarbiturates. While otherbarbiturates such asBarbital are usuallyanticonvulsants, CHEB is aconvulsant.

CHEB's convulsant action is not fully understood. There may be multiple mechanisms involved in its properties;

In rats, CHEB stimulates the release ofglutamate, an excitatoryneurotransmitter.[2]

In low doses, CHEB can block the action ofglycine, thus operating in astrychnine similar way.[3]

Another study has shown that CHEB could increase the release ofacetylcholine. This result was not observed with some other convulsants (S(+)-MPPB, pentylenetetrazol and Ro-5-3663), suggesting that this property is unique.[4]

Paradoxically, CHEB is able to enhance the binding ofGABA, this is a strange property, as compounds that enhance GABA binding usually haveanticonvulsant action, such asdiazepam.[5]

See also

[edit]

References

[edit]
  1. ^"5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate".
  2. ^Wei, L.; Schlame, M.; Downes, H.; Hemmings, H. C. (June 1996)."CHEB, a convulsant barbiturate, evokes calcium-dependent spontaneous glutamate release from rat cerebrocortical synaptosomes".Neuropharmacology.35 (6):695–701.doi:10.1016/0028-3908(96)84641-7.ISSN 0028-3908.PMID 8887978.
  3. ^Nicholson, G. M.; Spence, I.; Johnston, G. A. (June 1985)."Strychnine-like action of the convulsant barbiturate, CHEB".Neuropharmacology.24 (6):465–471.doi:10.1016/0028-3908(85)90050-4.ISSN 0028-3908.PMID 2862600.S2CID 31187813.
  4. ^Holtman, J. R.; Richter, J. A. (September 1983)."Increased release of [3H]acetylcholine in vitro from the mouse hippocampus by a convulsant barbiturate".Neuropharmacology.22 (9):1101–1108.doi:10.1016/0028-3908(83)90031-x.ISSN 0028-3908.PMID 6138729.S2CID 43453342.
  5. ^Willow, M; Johnston, GA (1981-04-01)."Enhancement by anesthetic and convulsant barbiturates of GABA binding to rat brain synaptosomal membranes".The Journal of Neuroscience.1 (4):364–367.doi:10.1523/JNEUROSCI.01-04-00364.1981.ISSN 0270-6474.PMC 6564141.PMID 6267224.
GABA receptor antagonists
GABA synthesis inhibitors
Glycine receptor antagonists
Glutamate receptor agonists
Convulsantbarbiturates
Other
Retrieved from "https://en.wikipedia.org/w/index.php?title=CHEB&oldid=1258627730"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp